(Bloomberg) -- Nobel Biocare Holding AG, the second-biggest dental-implant maker by sales, said first-quarter profit fell 67 percent and that it wants to buy AstraZeneca Plc’s dental implant business.
Net income dropped to 12.9 million euros ($19.2 million) from 38.7 million euros a year earlier, the Glattbrugg, Switzerland-based company said today in a statement. Profit fell short of the average estimate of 15.2 million euros from eight analysts surveyed by Bloomberg. The company had a currency gain of 30.1 million euros in last year’s first quarter.
